Review discusses nanoemulsion's promise in improving antibiotic delivery and addressing H. pylori's challenges.
Key Points
Nanoemulsion significantly enhances bioavailability of antibiotics to target H. pylori in the stomach lining, leading to improved eradication rates.
Current antibiotics often fail due to stomach acidity and biofilm formation by H. pylori, which complicates treatment and contributes to antibiotic resistance.
The review highlights the limitations of traditional therapies and the advantages of nanoemulsions, including controlled release and mucoadhesion potential.
This innovative drug delivery strategy presents a vital alternative for efficiently combating H. pylori infections and associated gastrointestinal diseases.